Skip to main content
Beilstein Journal of Organic Chemistry logoLink to Beilstein Journal of Organic Chemistry
. 2014 May 22;10:1213–1219. doi: 10.3762/bjoc.10.119

Syntheses of fluorooxindole and 2-fluoro-2-arylacetic acid derivatives from diethyl 2-fluoromalonate ester

Antal Harsanyi 1, Graham Sandford 1,, Dmitri S Yufit 2, Judith AK Howard 2
Editor: David O'Hagan
PMCID: PMC4077372  PMID: 24991270

Abstract

Diethyl 2-fluoromalonate ester is utilised as a building block for the synthesis of 2-fluoro-2-arylacetic acid and fluorooxindole derivatives by a strategy involving nucleophilic aromatic substitution reactions with ortho-fluoronitrobenzene substrates followed by decarboxylation, esterification and reductive cyclisation processes.

Keywords: fluorinated building blocks, fluoroarylacetic acid, fluoromalonate, fluorooxindole, organo-fluorine, selective fluorination

Introduction

Since 1954, when Fried and Sabo observed that the incorporation of a fluorine atom into a corticosteroid derivative led to valuable enhanced biological activity [1], a growing number of commercially significant life science products, which owe their activity to the presence of fluorine atoms within their structures, have developed. Fluorine incorporation can lead, for example, to enhanced bioavailability, metabolic stability and lipophilicity of the organic system and these properties are exploited in a number of commercially valuable drugs including Ciprofloxacin, Lipitor and Voriconazole [26].

Given the very small number of fluorinated systems available from nature [79], in essence all organic molecules bearing carbon–fluorine bonds are ‘man-made’. Syntheses rely either on the construction of carbon–fluorine bonds using a fluorinating agent (‘late-stage’ fluorination) or the application of polyfunctional fluorine-containing small molecule building blocks (‘early stage’ fluorination) which may be employed in further transformations involving all the reactions and techniques available to synthetic organic chemists [1013]. Of course, the success of an ‘early stage’ fluorination approach depends on the availability of a range of appropriately functionalised, fluorinated building blocks and the establishment of corresponding reactivity profiles [14]. However, it does not necessarily follow that reactions for which regio- and stereoselectivity profiles are well established for hydrocarbon systems will be similar to those for corresponding selectively fluorinated systems and, indeed, this is often not the case [15].

The use of 1,3-diketone, 1,3-ketoester and 1,3-diester derivatives in retrosynthetic planning is widespread in general organic chemistry and numerous terpenes, heterocycles and steroids originate from such simple yet synthetically versatile substrates [1619]. In contrast, despite the availability of synthetic procedures for the preparation of various 2-fluoro-1,3-dicarbonyl systems [2027], there is, surprisingly, only a relatively limited number of publications that report the use of such potentially useful fluorinated building blocks for the synthesis of more structurally sophisticated selectively fluorinated systems. For example, 2-fluoromalonate esters have been used for the preparation of various α-fluorocarboxylic acids [2832], heterocycles, such as fluoropyrimidine [33] and quinolone [34] derivatives, alkylated [35] and Michael addition [3640] products, providing an indication of the potential uses and opportunities available for the synthesis of fluoro-organic products from fluoromalonate precursors.

As part of a wider research programme aimed at developing routes for the synthesis of selectively fluorinated molecules using elemental fluorine for the key construction of the carbon–fluorine bond by complementary direct selective direct fluorination [4144], continuous flow [4549] and building block [50] strategies, in this paper, we describe nucleophilic aromatic substitution reactions of carbanions derived from diethyl 2-fluoromalonate ester as the first stage in the synthesis of fluoroacetic acid and fluoroxindole systems. While related palladium catalysed coupling processes between aryl bromides and diethyl 2-fluoromalonate have been described [51], reactions involving nucleophilic aromatic substitution between fluoromalonate systems [52] and appropriate aryl substrates have not been reported previously. Recently, various routes to fluorooxindoles have been discussed involving enantioselective fluorination of appropriate oxindole substrates by electrophilic fluorinating agents [5362] or DAST [63] providing an indication of the importance of fluorooxindoles for medicinal chemistry applications.

Results and Discussion

Reactions of carbanions generated by the addition of sodium hydride to a solution of diethyl 2-fluoromalonate (1) in DMF with ortho-fluoronitrobenzene (2a) led to the efficient displacement of fluorine by a nucleophilic aromatic substitution process to provide diester 3 in good yield (Scheme 1). Displacement of fluorine from ortho-fluoronitrobenzene was quantitative as measured by 19F NMR spectroscopy of the crude reaction mixture and the structure of isolated diester 3 was confirmed by X-ray crystallography (Figure 1).

Scheme 1.

Scheme 1

SNAr reaction of 2-fluoronitrobenzene (2a) with diethyl 2-fluoromalonate (1).

Figure 1.

Figure 1

Molecular structure of 3.

In initial experiments, decarboxylation of 3 by reaction with potassium hydroxide gave good yields of the corresponding 2-fluoro-2-arylacetic acid 4a. However, in subsequent experiments, we found that further purification of the diester 3 after the initial SNAr step was not necessary and decarboxylation of crude diester 3 gave 4a very efficiently. Consequently, in all analogous experiments (Table 1), crude product diesters of type 3 were isolated and used without further purification, allowing the ready synthesis of a range of arylfluoroacetic acid derivatives 4a–f (Table 1). Structures 4a–f were confirmed by NMR techniques and, in particular, a doublet located at −190 ppm (2JHF = 50 Hz) in the 19F NMR spectra assigned to the CFH resonances and the corresponding doublets observed at ~6 ppm in the 1H NMR spectra, are diagnostic for the structures proposed.

Table 1.

SNAr reactions using fluoromalonate derivatives.

graphic file with name Beilstein_J_Org_Chem-10-1213-i001.jpg

Fluoronitroaryl 2 Fluoroarylacetic acid 4 Yield

Inline graphic
2a
Inline graphic
4a
62%
Inline graphic
2b
Inline graphic
4b
77%
Inline graphic
2c
Inline graphic
4c
83%
Inline graphic
2d
Inline graphic
4d
56%
Inline graphic
2e
Inline graphic
4e
60%
Inline graphic
2f
Inline graphic
4f
86%

A nitro group ortho to a fluorine atom on the aryl ring is necessary under the present conditions to achieve full conversion of the starting fluoroarene. In related experiments, we found that a para-trifluoromethyl group is not sufficiently activating for reaction to occur whilst para-fluoronitrobenzene gave a complex mixture of unidentified products, most probably derived from competing benzyne formation.

This efficient methodology complements reported processes for the synthesis of various biologically active 2-fluoro-2-phenylacetic acids [64] which may be prepared using electrophilic fluorination of enolate esters [6466], deoxofluorination [6769] nucleophilic [70] and electrochemical fluorination [7172] strategies.

Attempts to prepare 2-fluoro-2-(2,4-dinitrophenyl)acetic acid by an analogous process led to the isolation of a benzyl fluoride derivative 5, after evaporation of toluene and purification by column chromatography in 61% yield. The two consecutive decarboxylation reactions reflect the greater stability of the benzylic carbanion formed on loss of carbon dioxide from this system (Scheme 2).

Scheme 2.

Scheme 2

Synthesis of benzyl fluoride derivative 5.

With the series of 2-fluorophenylacetic acids in hand, we attempted the reduction of the nitro group in 4a using sodium dithionite, adapting reaction conditions similar to those described in the literature for the synthesis of biologically active system MaxiPost [63]. However, very low isolated yields of the cyclised product were obtained, presumably because of the high solubility of the amino acid intermediate in the aqueous reaction mixture and the well-established difficulty of direct amide bond formation processes. Consequently, before carrying out the nitro group reduction and amide forming cyclisation reactions, the acids 4a–e were transformed to the corresponding methyl esters 6a–e by stirring a mixture of the acid in hydrochloric acid and methanol (Table 2). The structure of 6a was confirmed unambiguously by X-ray crystallography (Figure 2) and all other methyl esters 6b–e were characterised by comparison with appropriate NMR data obtained for 6a.

Table 2.

Synthesis of methyl ester derivatives.

graphic file with name Beilstein_J_Org_Chem-10-1213-i014.jpg

Fluoroacetic acid 4 Methyl ester 6 Yield

Inline graphic
4a
Inline graphic
6a
88%
Inline graphic
4b
Inline graphic
6b
98%
Inline graphic
4c
Inline graphic
6c
97%
Inline graphic
4d
Inline graphic
6d
65%
Inline graphic
4e
Inline graphic
6e
98%

Figure 2.

Figure 2

Molecular structure of methyl ester 6a.

However, corresponding attempted esterification of the salt 4f with HCl in methanol gave 2-fluoromethyl-3-nitropyridine (7) in 68% yield (Scheme 3) after purification of the crude material by column chromatography and the structure was confirmed by X-ray analysis (Figure 3). In this case competing decarboxylation, rather than esterification, reflects the greater stabilisation of the carbanion system formed upon decarboxylation for this system.

Scheme 3.

Scheme 3

Synthesis of pyridyl fluoride 7.

Figure 3.

Figure 3

Molecular structure of 7.

Reductive cyclization of methyl esters 6a–e using sodium dithionite provided fluorooxindoles 8a–e in acceptable yield after isolation by column chromatography (Table 3). In the 1H NMR spectrum, the characteristic CHF doublet located at 5.7 ppm (2JHF = 51 Hz) for the fluorooxindole systems 8 are 0.9 ppm upfield from the corresponding CHF resonances of the arylfluoroacetic esters 6a–e and, additionally, a broad NH singlet was detected at 9.0 ppm. The chemical shift of the doublet (−194.8 ppm) in the 19F NMR spectrum of fluorooxindoles 8a–e is also observed 10 ppm upfield from the fluorine resonance of the starting esters 6a–e.

Table 3.

Synthesis of 3-fluorooxindoles.

graphic file with name Beilstein_J_Org_Chem-10-1213-i025.jpg

Methyl ester 6 Fluorooxindole 8 Yield

Inline graphic
6a
Inline graphic
8a
32%
Inline graphic
6b
Inline graphic
8b
82%
Inline graphic
6c
Inline graphic
8c
57%
Inline graphic
6d
Inline graphic
8d
0%
Inline graphic
6e
Inline graphic
8e
30%

Conclusion

Diethyl 2-fluoromalonate ester can be used as a highly effective fluorinated building block for the synthesis of various polyfunctional 2-fluoroacetic acid and 3-fluorooxindole systems. Fluorooxindoles are relatively rare fluorinated heterocyclic systems, even though several derivatives have useful biological activity, and current literature syntheses only involve fluorination of appropriate hydroxy and oxindole substrates. The strategy described here provides complementary building block syntheses from readily available fluorinated starting materials, further demonstrating the viability of using fluorinated dicarbonyl systems for the synthesis of more structurally sophisticated fluorinated derivatives.

Supporting Information

File 1

Experimental procedures.

File 2

NMR spectra.

File 3

X-ray crystallographic data.

This article is part of the Thematic Series "Organo-fluorine chemistry III".

References

  • 1.Fried J, Sabo E F. J Am Chem Soc. 1954;76:1455–1456. doi: 10.1021/ja01634a101. [DOI] [Google Scholar]
  • 2.Müller K, Faeh C, Diedrich F. Science. 2007;317:1881–1886. doi: 10.1126/science.1131943. [DOI] [PubMed] [Google Scholar]
  • 3.Ojima I, editor. Fluorine in Medicinal Chemistry and Chemical Biology. Oxford: Wiley-Blackwell; 2009. [Google Scholar]
  • 4.Purser S, Moore P R, Swallow S, Gouverneur V. Chem Soc Rev. 2008;37:320–330. doi: 10.1039/b610213c. [DOI] [PubMed] [Google Scholar]
  • 5.Isanbor C, O'Hagan D. J Fluorine Chem. 2006;127:303–319. doi: 10.1016/j.jfluchem.2006.01.011. [DOI] [Google Scholar]
  • 6.Kirk K L. J Fluorine Chem. 2006;127:1013–1029. doi: 10.1016/j.jfluchem.2006.06.007. [DOI] [Google Scholar]
  • 7.Gribble G W. Chem Soc Rev. 1999;28:335–346. doi: 10.1039/a900201d. [DOI] [Google Scholar]
  • 8.Hall R J. New Phytol. 1972;71:855–871. doi: 10.1111/j.1469-8137.1972.tb01965.x. [DOI] [Google Scholar]
  • 9.O'Hagan D, Schaffrath C, Cobb S L, Hamilton J T G, Murphy C D. Nature. 2002;416:279. doi: 10.1038/416279a. [DOI] [PubMed] [Google Scholar]
  • 10.Baasner B, Hagemann H, Tatlow J C. Houben-Weyl Organofluorine Compounds. E10a. Stuttgart: Thieme; 2000. [Google Scholar]
  • 11.Chambers R D. Fluorine in Organic Chemistry. Oxford: Blackwell; 2004. [Google Scholar]
  • 12.Uneyama K. Organofluorine Chemistry. Oxford: Blackwell; 2006. [DOI] [Google Scholar]
  • 13.Liang T, Neumann C N, Ritter T. Angew Chem, Int Ed. 2013;52:8214–8264. doi: 10.1002/anie.201206566. [DOI] [PubMed] [Google Scholar]
  • 14.Percy J M. Top Curr Chem. 1997;199:131–195. doi: 10.1007/3-540-69197-9_4. [DOI] [Google Scholar]
  • 15.Seebach D. Angew Chem, Int Ed Engl. 1990;29:1320–1367. doi: 10.1002/anie.199013201. [DOI] [Google Scholar]
  • 16.Warren S. Designing Organic Syntheses: A Progrmmed Introduction to the Synthon Approach. New York: John Wiley and Sons; 1978. [Google Scholar]
  • 17.Warren S, Wyatt P. Organic Synthesis: The Disconnection Approach. 2nd ed. Chichester: John Wiley and Sons; 2008. [Google Scholar]
  • 18.Wyatt P, Warren S. Organic Synthesis: Strategy and Control. 2nd ed. Chichester: John Wiley and Sons; 2007. [Google Scholar]
  • 19.Corey E J, Cheng X-M. The logic of chemical synthesis. New York: John Wiley and Sons; 1995. [Google Scholar]
  • 20.Chambers R D, Hutchinson J, Thomson J. J Fluorine Chem. 1996;78:165–166. doi: 10.1016/0022-1139(96)03422-7. [DOI] [Google Scholar]
  • 21.Chambers R D, Fox M A, Holling D, Nakano T, Okazoe T, Sandford G. Chem Eng Technol. 2005;28:344–352. doi: 10.1002/ceat.200407123. [DOI] [Google Scholar]
  • 22.Chambers R D, Hutchinson J. J Fluorine Chem. 1998;92:45–52. doi: 10.1016/S0022-1139(98)00254-1. [DOI] [Google Scholar]
  • 23.Müh T, Fiedler P, Weintritt H, Westerkamp W, Reinecke A, inventors. Method for producing alpha fluoromalonic acid dialkyl esters. WO2002016304. W.O. Patent. 2002 Feb 28;
  • 24.Günther A, Weintritt H, Böhm S, inventors. Method for producing a-fluoromalonic acid dialkyl esters. WO2005019154. W.O. Patent. 2005 Mar 3;
  • 25.Braun M, Brosch C, inventors. Production of fluorine compounds. WO2002060838. W.O. Patent. 2002 Aug 8;
  • 26.Ishikawa N, Takaoka A. Chem Lett. 1981;10:107–110. doi: 10.1246/cl.1981.107. [DOI] [Google Scholar]
  • 27.Ishikawa N, Takaoka A, Ibrahim M K. J Fluorine Chem. 1984;25:203–212. doi: 10.1016/S0022-1139(00)80949-5. [DOI] [Google Scholar]
  • 28.Miller T A, Sloman D L, Stanton M G, Wilson K J, Witter D J, inventors. Fluorinated arylamide derivatives. WO2007087129. W.O. Patent. 2007 Aug 2;
  • 29.Close J, Heidebrecht R W, Kattar S, Miller T A, Sloman D, Stanton M G, Tempest P, Witter D J, inventors. Histone deacetylase inhibitors with aryl-pyrazolyl motifs. WO2007055941. W.O. Patent. 2007 May 18;
  • 30.Hubbs J L, Mampreian D M, Methot J L, Miller T A, Otte K M, Siliphaivanh P, Sloman D L, Stanton M G, Wilson K J, Witter D J, inventors. Benzothiophene derivatives. WO2006115845. W.O. Patent. 2006 Nov 2;
  • 31.Bressi J C, Chu S, Erickson P, Komandla M, Kwok L, Lawson J D, Stafford J A, Wallace M B, Zhang Z, Das J, inventors. cMET inhibitors. WO2010019899. W.O. Patent. 2010 Feb 18;
  • 32.Leonardi A, Riva C, Tavecchia P, Sironi G, inventors. Aldosterone receptor antagonists. WO2007025780. W.O. Patent. 2007 Mar 8;
  • 33.Bergmann E D, Cohen S, Shahak I. J Chem Soc. 1959:3286–3289. doi: 10.1039/jr9590003286. [DOI] [Google Scholar]
  • 34.Brickner S J, Chen J M, Li Z B, Marfat A, Mitton-Fry M J, Plotkin M A, Reilly U D, Subramanyam C, Zhang Z, Robinson S, inventors. Substituted heterocyclic derivatives and their pharmaceutical use and compositions. US20080280879. U.S. Patent. 2008 Nov 13;
  • 35.Polla M O, Tottie L, Nordén C, Linschoten M, Müsil D, Trumpp-Kallmeyer S, Aukrust I R, Ringom R, Holm K H, Neset S M, et al. Bioorg Med Chem. 2004;12:1151–1175. doi: 10.1016/j.bmc.2003.12.039. [DOI] [PubMed] [Google Scholar]
  • 36.Kim D-Y, Kim S-M, Koh K-O, Mang J-Y, Lee K-S. Bull Korean Chem Soc. 2003;24:1425–1426. doi: 10.5012/bkcs.2003.24.10.1425. [DOI] [Google Scholar]
  • 37.Cho M-J, Cho M-G, Huh S-C, Kim S-M, Lee K-s, Koh K-O, Mang J-Y, Kim D-Y. Bull Korean Chem Soc. 2006;27:857–862. doi: 10.5012/bkcs.2006.27.6.857. [DOI] [Google Scholar]
  • 38.Kang S-H, Kim D-Y. Bull Korean Chem Soc. 2009;30:1439–1440. doi: 10.5012/bkcs.2009.30.7.1439. [DOI] [Google Scholar]
  • 39.Kwon B K, Kim S M, Kim D Y. J Fluorine Chem. 2009;130:759–761. doi: 10.1016/j.jfluchem.2009.06.002. [DOI] [Google Scholar]
  • 40.Li H, Zu L, Xie H, Wang W. Synthesis. 2009:1525–1530. doi: 10.1055/s-0028-1088124. [DOI] [Google Scholar]
  • 41.Sandford G. J Fluorine Chem. 2007;128:90–104. doi: 10.1016/j.jfluchem.2006.10.019. [DOI] [Google Scholar]
  • 42.Chambers R D, Nakano T, Parsons M, Sandford G, Batsanov A S, Howard J A K. J Fluorine Chem. 2008;129:811–816. doi: 10.1016/j.jfluchem.2008.04.010. [DOI] [Google Scholar]
  • 43.Chambers R D, Sandford G, Trmcic J, Okazoe T. Org Process Res Dev. 2008;12:339–344. doi: 10.1021/op700194r. [DOI] [Google Scholar]
  • 44.Chambers R D, Nakano T, Okazoe T, Sandford G. J Fluorine Chem. 2009;130:792–798. doi: 10.1016/j.jfluchem.2009.06.003. [DOI] [Google Scholar]
  • 45.Chambers R D, Fox M A, Holling D, Nakano T, Okazoe T, Sandford G. Lab Chip. 2005;5:191–198. doi: 10.1039/b416400h. [DOI] [PubMed] [Google Scholar]
  • 46.Chambers R D, Fox M A, Holling D, Nakano T, Okazoe T, Sandford G. Chem Eng Technol. 2005;28:344–352. doi: 10.1002/ceat.200407123. [DOI] [Google Scholar]
  • 47.Chambers R D, Fox M A, Sandford G. Lab Chip. 2005;5:1132–1139. doi: 10.1039/b504675k. [DOI] [PubMed] [Google Scholar]
  • 48.Breen J R, Sandford G, Yufit D S, Howard J A K, Fray J, Patel B. Beilstein J Org Chem. 2011;7:1048–1054. doi: 10.3762/bjoc.7.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.McPake C B, Sandford G. Org Process Res Dev. 2012;16:844–851. doi: 10.1021/op200331s. [DOI] [Google Scholar]
  • 50.Hutchinson J, Sandford G, Vaughan J F S. Tetrahedron. 1998;54:2867–2876. doi: 10.1016/S0040-4020(98)83023-8. [DOI] [Google Scholar]
  • 51.Beare N A, Hartwig J F. J Org Chem. 2002;67:541–555. doi: 10.1021/jo016226h. [DOI] [PubMed] [Google Scholar]
  • 52.Harsanyi, A. M.Sc. Thesis, Synthesis of 3-fluoro-oxindoles and phenyl fluoroacetic acid derivatives; Durham University, 2013, available from http://etheses.dur.ac.uk/6357/.
  • 53.Shibata N, Suzuki E, Asahi T, Shiro M. J Am Chem Soc. 2001;123:7001–7009. doi: 10.1021/ja010789t. [DOI] [PubMed] [Google Scholar]
  • 54.Shibata N, Ishimaru T, Suzuki E, Kirk K L. J Org Chem. 2003;68:2494–2497. doi: 10.1021/jo026792s. [DOI] [PubMed] [Google Scholar]
  • 55.Zoute L, Audouard C, Plaquevent J-C, Cahard D. Org Biomol Chem. 2003;1:1833–1834. doi: 10.1039/b303113f. [DOI] [PubMed] [Google Scholar]
  • 56.Shibata N, Kohno J, Takai K, Ishimaru T, Nakamura S, Toru T, Kanemasa S. Angew Chem, Int Ed. 2005;44:4204–4207. doi: 10.1002/anie.200501041. [DOI] [PubMed] [Google Scholar]
  • 57.Hamashima Y, Suzuki N, Takano H, Shimura Y, Sodeoka M. J Am Chem Soc. 2005;127:10164–10165. doi: 10.1021/ja0513077. [DOI] [PubMed] [Google Scholar]
  • 58.Deng Q-H, Wadepohl H, Gade L H. Chem–Eur J. 2011;17:14922–14928. doi: 10.1002/chem.201102375. [DOI] [PubMed] [Google Scholar]
  • 59.Li J, Cai Y, Chen W, Liu X, Lin L, Feng X. J Org Chem. 2012;77:9148–9155. doi: 10.1021/jo301705t. [DOI] [PubMed] [Google Scholar]
  • 60.Wu L, Falivene L, Drinkel E, Grant S, Linden A, Cavallo L, Dorta R. Angew Chem, Int Ed. 2012;51:2870–2873. doi: 10.1002/anie.201200206. [DOI] [PubMed] [Google Scholar]
  • 61.Ishimaru T, Shibata N, Horikawa T, Yasuda N, Nakamura S, Toru T, Shiro M. Angew Chem, Int Ed. 2008;47:4157–4161. doi: 10.1002/anie.200800717. [DOI] [PubMed] [Google Scholar]
  • 62.Dou X, Lu Y. Org Biomol Chem. 2013;11:5217–5221. doi: 10.1039/c3ob41267a. [DOI] [PubMed] [Google Scholar]
  • 63.Hewawasam P, Gribkoff V K, Pendri Y, Dworetzky S I, Meanwell N A, Martinez E, Boissard C G, Post-Munson D J, Trojnacki J T, Yeleswaram K, et al. Bioorg Med Chem Lett. 2002;12:1023–1026. doi: 10.1016/S0960-894X(02)00101-4. [DOI] [PubMed] [Google Scholar]
  • 64.Schiefer I T, Abdul-Hay S, Wang H, Vanni M, Qin Z, Thatcher G R J. J Med Chem. 2011;54:2293–2306. doi: 10.1021/jm101450p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Zhang F, Song J Z. Tetrahedron Lett. 2006;47:7641–7644. doi: 10.1016/j.tetlet.2006.08.057. [DOI] [Google Scholar]
  • 66.Rozen S, Hagooly A, Harduf R. J Org Chem. 2001;66:7464–7468. doi: 10.1021/jo010677k. [DOI] [PubMed] [Google Scholar]
  • 67.Davis F A, Han W, Murphy C K. J Org Chem. 1996;60:4730–4737. doi: 10.1021/jo00120a014. [DOI] [Google Scholar]
  • 68.Cantrell G L, Filler R. J Fluorine Chem. 1985;27:35–45. doi: 10.1016/S0022-1139(00)80895-7. [DOI] [Google Scholar]
  • 69.Bresciani S, O’Hagan D. Tetrahedron Lett. 2010;51:5795–5797. doi: 10.1016/j.tetlet.2010.08.104. [DOI] [Google Scholar]
  • 70.Watanabe S, Fujita T, Sakamoto M, Endo H, Kitazume T. J Fluorine Chem. 1990;47:187–192. doi: 10.1016/S0022-1139(00)82371-4. [DOI] [Google Scholar]
  • 71.Kim K-Y, Kim B C, Lee H B, Shin H. J Org Chem. 2008;73:8106–8108. doi: 10.1021/jo8015659. [DOI] [PubMed] [Google Scholar]
  • 72.Yin J, Zarkowsky D S, Thomas D W, Zhao M M, Huffman M A. Org Lett. 2004;6:1465–1468. doi: 10.1021/ol049672a. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

File 1

Experimental procedures.

File 2

NMR spectra.

File 3

X-ray crystallographic data.


Articles from Beilstein Journal of Organic Chemistry are provided here courtesy of Beilstein-Institut

RESOURCES